EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Désirée van der Heijde, Robert Landewé et al.|Annals of the Rheumatic Diseases|2020Cited by 2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Désirée van der Heijde, Robert Landewé et al.|Annals of the Rheumatic Diseases|2022Cited by 1.9k
2022 updateJosef S Smolen, Josef S. Smolen, Robert Landewé et al.|Radboud Repository (Radboud University)|2010Cited by 1.6k
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Philippe Goupille, Milena Gianfrancesco et al.|JAMA Network Open|2021Cited by 117
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Philip C Robinson, Milena Gianfrancesco et al.|The Lancet Rheumatology|2022Cited by 19